WAM
BPTH

Warberg Asset Management’s Bio-Path Holdings Inc BPTH Stock Holding History

Warberg Asset Management’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,200
Closed -$8.88K – 277
2023
Q3 		$8.88K Buy
+1,200
New +$16.7K ﹤0.01% 179

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SA
Strategic Advocates Logan, Utah $22.6M AUM 26.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Warberg Asset Management's BPTH Position: Q4 2023 in Review

Warberg Asset Management sold out of Bio-Path Holdings Inc (BPTH) in Q4 2023, closing a stake of 1,200 shares — an estimated $8.88K sold.

Warberg Asset Management first reported a position in BPTH in Q3 2023 and held it in 1 quarter. The position peaked at $8.88K in Q3 2023. 19 funds tracked by Wall St. Rank hold BPTH as of Q4 2023.

  • Warberg Asset Management reported no remaining Bio-Path Holdings Inc position as of Q4 2023 after selling out during the quarter.
  • Warberg Asset Management sold 1,200 Bio-Path Holdings Inc shares in Q4 2023, an estimated $8.88K.
  • Warberg Asset Management first reported a position in Bio-Path Holdings Inc in Q3 2023 and held it in 1 quarter.
  • Warberg Asset Management's Bio-Path Holdings Inc position peaked at $8.88K in Q3 2023.
  • 19 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2023.

Based on Warberg Asset Management's 13F filing for Q4 2023, filed 7 Feb 2024.